| 2026-02-19 | UPC_CFI_26/2025 | Vienna LD | Infringement Action | Infringement merits | Not infringed | The Vienna Local Division dismissed both Messerle GmbH's infringement action and Sabert Corporation Europe's counterclaim for revocation concerning EP 3 705 415 B1 (a packaging-related patent). The infringement action was dismissed because the accused 'Tray2Go' product did not directly or equivalently infringe the patent claims — the Court found no technical-functional equivalence of the substitute means used in the accused product. The counterclaim for revocation was also dismissed, so the patent was maintained as granted. Each party bears its own costs (maximum EUR 600,000 total, split evenly between action and counterclaim). |
| 2025-12-19 | UPC_CFI_660/2024 | Mannheim LD | Infringement Action | Infringement merits | Revoked | The Court revoked European patent EP 3 652 914 B1 in its entirety in the territories of France and Germany on the basis of the counterclaim for revocation filed by Palo Alto Networks. The claims (including the unconditionally amended main request and all auxiliary requests) were found to lack inventive step in light of the prior art. As a consequence, the infringement action was dismissed. Centripetal was ordered to bear the costs of the litigation. The value in dispute was set at EUR 2 million (EUR 1 million each for the infringement action and counterclaim). |
| 2025-12-05 | UPC_CFI_775/2025 | Nordic-Baltic RD | Application RoP262A | Procedural | Procedural only | The Nordic-Baltic Regional Division stayed the cost proceedings between Edwards Lifesciences and Meril pending the outcome of EPO Board of Appeal opposition proceedings against EP 3 769 722, and provisionally ordered confidentiality obligations by mutual agreement of the parties. |
| 2025-09-02 | UPC_APP_35269/2025 | Nordic-Baltic RD | Generic application | Costs | Procedural only | Order of the Nordic-Baltic Regional Division in Edwards Lifesciences v Meril Life Sciences et al. (EP 3 769 722) on a request for rectification of the decision on the merits of 21 July 2025. The prior decision on the merits found the patent invalid as granted but upheld it as amended, and found infringement of the amended patent. The operative part of that decision ordered the defendants to bear 100% of Edwards' costs in the infringement action and 75% of Edwards' costs in the revocation counterclaim proceedings. The defendants requested rectification to add an obligation on Edwards to bear 25% of the defendants' costs in the revocation proceedings. The rectification request is the subject of this order. |
| 2025-07-31 | ACT_953/2024 | Nordic-Baltic RD | Infringement Action | Infringement merits | Infringed | Decision by Nordic-Baltic Regional Division (UPC_CFI_9/2024, 31 July 2025) finding Sioen NV liable for infringement of EP 2 186 428 B2 (protective workwear / clothing) across 16 UPC member states. An injunction was granted, product recall and destruction ordered, information on sales required, damages declared owing, and EUR 50,000 awarded as interim legal costs. All other requests were dismissed. |
| 2025-07-21 | UPC_CFI_380/2023 | Nordic-Baltic RD | Infringement Action | — | outcomeName.other | Decision of the Nordic-Baltic Regional Division dated 21 July 2025 (anonymised) in Edwards Lifesciences Corporation's infringement action against Meril Life Sciences Pvt Limited and related entities regarding EP 3 769 722 (heart valve delivery system). The decision covers the infringement action and multiple counterclaims for revocation filed by Meril entities, as well as applications to amend the patent. The oral hearing was held on 16 January 2025, with further pleadings submitted after the hearing regarding parallel EPO opposition proceedings. The operative part of the decision is not included in the available excerpt; however given the case involves both infringement claims and revocation counterclaims with patent amendment applications, a substantive ruling on both infringement and validity is expected. |
| 2025-07-21 | UPC_CFI_8/2023 | Nordic-Baltic RD | Application Rop 365 | — | Settled | The court confirmed a settlement agreement between Edwards Lifesciences Corporation and the Meril defendants (Meril Lifesciences PVT Limited, Meril GmbH, SMIS International OÜ, and Sormedica UAB) in the infringement action and related counterclaims for revocation concerning EP 2 628 464. Both the infringement action and counterclaims for revocation were settled and confirmed by decision. The court also ordered partial reimbursement of court fees. |
| 2025-04-23 | UPC_CFI_452/2024 | Nordic-Baltic RD | Application Rop 265 | — | Withdrawn | The Nordic-Baltic Regional Division declared proceedings closed following the mutual withdrawal of Viking Arm AS's infringement action and Stanley Black & Decker's counterclaim for revocation concerning EP 3 953 541. Both parties consented to each other's withdrawal and agreed that no cost decision was required. |
| 2025-02-27 | UPC_APP_7494/2025 | Nordic-Baltic RD | Application Rop 265 | Procedural | Settled | The Nordic-Baltic Regional Division declared provisional measures proceedings between Fapa Vital AG and Valentis Baltic UAB concerning EP1978949 closed following the applicant's withdrawal after a settlement, ordered 60% reimbursement of court fees under R.370.9(b)(i) RoP, and declined to issue a cost decision as agreed by the parties. |
| 2025-01-21 | UPC_APP_33375/2024 | Nordic-Baltic RD | Application RoP262.1 (b) | Procedural | Dismissed | Nordic-Baltic Regional Division judge-rapporteur closed proceedings following withdrawal of seven public access applications (R. 262.1(b) RoP) by the applicant (an individual acting also on behalf of SWAT Medical AB) in Edwards Lifesciences Corporation v. Meril et al. proceedings. Meril Life Sciences PVT Limited's request for cost reimbursement (EUR 17,168.70) was rejected: Art. 69 UPCA does not apply to proceedings on public access requests because (i) the Enforcement Directive's cost principle does not extend to such requests, (ii) no ceiling for recoverable costs has been set for access proceedings, and (iii) parties to the main proceedings are merely consulted, not 'parties' in the access sub-proceedings. |
| 2025-01-20 | UPC_APP_68693/2024 | Nordic-Baltic RD | Application Rop 265 | Procedural | Withdrawn | The Nordic-Baltic Regional Division declared the proceedings closed following the mutual withdrawal of Abbott Diabetes Care's infringement action and Dexcom's counterclaim for revocation (both relating to EP 3 977 921). Both parties consented to withdrawal with no cost decision requested or made. |
| 2025-01-20 | UPC_APP_68369/2024 | Nordic-Baltic RD | Application Rop 265 | Procedural | Withdrawn | The Nordic-Baltic Regional Division permitted the withdrawal of Abbott Diabetes Care Inc.'s infringement action (ACT_588346/2023) and Dexcom's counterclaim for revocation (CC_14848/2024) in Abbott v Dexcom proceedings (UPC 430/2023, EP 3 977 921). Both parties consented to each other's withdrawals and agreed that no costs order would be made. The Court declared the proceedings closed. |
| 2025-01-20 | UPC_CFI_430/2023 | Nordic-Baltic RD | Application Rop 265 | — | Withdrawn | The Nordic-Baltic Regional Division declared proceedings closed following the mutual withdrawal of Abbott Diabetes Care Inc.'s infringement action and Dexcom's counterclaim for revocation concerning EP 3 977 921. Both parties consented to each other's withdrawal and agreed that no cost decision would be issued. |
| 2024-12-11 | ORD_65290/2024 | Nordic-Baltic RD | Generic Order | Procedural | Procedural only | Nordic-Baltic Regional Division (full panel) order dismissing defendants' request to stay the main infringement proceedings pending EPO opposition proceedings concerning EP 3 769 722. The Court of Appeal had previously set aside an earlier stay dismissal and referred back for reconsideration under R. 295(a) RoP. On reconsideration, the panel dismissed the stay request again in the Meril/Edwards heart valve case (Edward Lifesciences v Meril entities). The request to stay pending Central Division revocation counterclaim was also refused. |
| 2024-12-10 | ACT_582093/2023 | Nordic-Baltic RD | Infringement Action | Procedural | Procedural only | The Nordic-Baltic Regional Division issued a post-interim conference procedural order in Edwards Lifesciences Corporation v Meril Life Sciences and others (UPC_CFI_380/2023, EP 3 769 722 — a transcatheter heart valve patent). The order resolved multiple procedural disputes including: admissibility of additional invalidity attacks raised in the counterclaim for revocation; how to deal with the public interest defence; request for a CJEU preliminary reference (deferred); request for a Court expert (rejected); and practical arrangements for the oral hearing. |
| 2024-10-29 | UPC_APP_10381/2024 | Nordic-Baltic RD | Preliminary objection | motionName.jurisdictional | Procedural only | The Nordic-Baltic Regional Division rejected Sioen NV's preliminary objection in the patent infringement action brought by TEXPORT, finding that parallel Belgian proceedings (for non-infringement declaration regarding the Belgian part of the patent) did not preclude UPC jurisdiction over infringements in Latvia and Portugal under Arts. 29–31 of Brussels I Recast. |
| 2024-10-29 | ACT_953/2024 | Nordic-Baltic RD | Infringement Action | Procedural | Procedural only | The Nordic-Baltic Regional Division issued a post-interim-conference order in infringement proceedings, setting the value of the action at EUR 500,000, closing the written procedure, partially referring a preliminary objection issue to main proceedings, and allowing certain expert evidence previously contested by the defendant. |
| 2024-10-07 | ORD_55063/2024 | Nordic-Baltic RD | Generic Order | Procedural | Procedural only | Nordic-Baltic Regional Division (judge-rapporteur Kai Härmand) preliminary/case management order in Abbott Diabetes Care Inc.'s infringement action against Dexcom Inc. and Dexcom International Limited concerning EP 3 977 921 (a continuous glucose monitoring patent). The order addresses multiple pending applications including Abbott's R. 190 application to communicate information (partially dismissed following Paris LD precedent), Abbott's R. 191 application (found admissible but not justified), Abbott's application to change the statement of claim, Dexcom's request for security for legal costs, and sets procedural deadlines and oral hearing preparation steps. |
| 2024-09-18 | UPC_APP_33494/2024 | Nordic-Baltic RD | Application RoP262.1 (b) | Procedural | Procedural only | Procedural order of the Nordic-Baltic Regional Division (full panel) on the same anonymized applicant's third parallel request for access to pleadings and evidence under Rule 262.1(b) RoP in the Edwards Lifesciences v. Meril proceedings (EP 2 628 464). Filed as App_33494/2024, this order applies the same legal principles on public access as the companion orders in App_33316/2024 and App_33493/2024, with substantially identical headnotes and analysis. |
| 2024-09-18 | UPC_APP_33493/2024 | Nordic-Baltic RD | Application RoP262.1 (b) | Procedural | Procedural only | Procedural order of the Nordic-Baltic Regional Division (full panel) on the same anonymized applicant's request for access to pleadings and evidence under Rule 262.1(b) RoP in the Edwards Lifesciences v. Meril proceedings (EP 2 628 464). This is a parallel order filed in the counterclaim proceedings under App. 33493/2024, applying the same legal principles as App_33316/2024. The headnotes and legal analysis concerning public access under Art. 45 UPCA are substantially identical to the order in App_33316/2024. |
| 2024-09-18 | UPC_APP_33316/2024 | Nordic-Baltic RD | Application RoP262.1 (b) | Procedural | Procedural only | Procedural order of the Nordic-Baltic Regional Division (full panel) on an anonymized applicant's request for access to pleadings and evidence under Rule 262.1(b) RoP in the Edwards Lifesciences v. Meril infringement proceedings (EP 2 628 464). The court set out important headnotes on public access: Art. 45 UPCA establishes a principle of openness of UPC proceedings including written procedure, and if an applicant has provided a credible explanation for seeking access, the application should be approved unless confidentiality is necessary. The court addressed whether the applicant's stated interest was sufficient to justify granting access. |
| 2024-08-20 | UPC_APP_14299/2024 | Nordic-Baltic RD | Generic application | Procedural | Procedural only | Order by Nordic-Baltic Regional Division (UPC_CFI_380/2023, 20 August 2024) dismissing Meril defendants' application to stay infringement proceedings pending EPO opposition on EP 3 769 722 (transcatheter heart valve). The court clarified that R. 295(a) RoP and Art. 33(10) UPCA allow a discretionary stay during written procedure only if a rapid EPO decision is expected; R. 118.2(b) RoP applies only in the oral procedure phase. |
| 2024-08-20 | UPC_APP_14061/2024 | Nordic-Baltic RD | Generic application | Procedural | Procedural only | Procedural order from the Nordic-Baltic Regional Division (UPC_CFI_380/2023) dismissing Meril entities' application for security for costs against Edwards Lifesciences in an infringement action concerning EP 3 769 722. The Court held that the mere fact that the claimant is located in the United States does not justify ordering security for costs, as this would constitute an unjustified restriction of the right to an effective remedy; the risk of unenforceability in the US was deemed insufficient. |
| 2024-08-16 | UPC_APP_43606/2024 | Nordic-Baltic RD | Generic application | Procedural | Procedural only | The Nordic-Baltic Regional Division issued a procedural order setting the timetable for resumption of Edwards Lifesciences' infringement action against Meril entities after a stay pending EPO Technical Board of Appeal decision in T0308/23 concerning EP 2 628 464. |
| 2023-10-17 | UPC_CFI_11/2023 | Nordic-Baltic RD | Infringement Action | Procedural | Procedural only | The Nordic-Baltic Regional Division partially granted a Rule 262.1(b) request for public access to pleadings and evidence, holding that under Article 45 UPCA written proceedings are in principle public, and that a credible explanation for why access is sought is sufficient unless confidentiality is necessary. |
| 2023-09-08 | UPC_CFI_11/2023 | Nordic-Baltic RD | Infringement Action | Procedural | Procedural only | The Nordic Baltic Regional Division issued a procedural order in OCADO's infringement proceedings against AUTOSTORE, addressing scheduling and related case management matters; the order is sparsely documented in the available excerpt. |